Concord Biotech Ltd receives GMP certificate from Kenya regulator

The Ministry of Health Pharmacy and Poisons Board, Republic of Kenya had conducted inspection of Unit II (formulation facility) of Concord Biotech Limited, located at Valthera-Dholka (Unit II) in Ahmedabad, Gujarat.

The said inspection has been completed successfully, without any adverse remarks and the company has received the certificate of Good manufacturing practices (GMP) as on today (i.e. 22nd February, 2024).

The said Unit complies with the prescribed Good Manufacturing practices as per relevant WHO technical Report Series and other internationally acceptable guidelines.

Shares of Concord Biotech Limited was last trading in BSE at Rs. 1442.80 as compared to the previous close of Rs. 1385.40. The total number of shares traded during the day was 7545 in over 694 trades.

The stock hit an intraday high of Rs. 1465.00 and intraday low of 1392.05. The net turnover during the day was Rs. 10634121.00.

Source : Equity Bulls

Keywords

ConcordBiotech Pharmaceuticals INE338H01029 Kenya Inspection GMP Unit2 FormulationFacility Ahmedabad Gujarat